Carmen Espinet Mestre
Grau: Doctor/a
carme.espinet(ELIMINAR)@udl.cat
ResearcherID: http://www.researcherid.com/rid/A-7950-2010
Publicacions
-
Roy R; Lorca C; Mulet M; Sánchez Milán JA; Baratas A; de la Casa M; Espinet C; Serra A; Gallart-Palau X
Altered ureido protein modification profiles in seminal plasma extracellular vesicles of non-normozoospermic men.
Frontiers in Endocrinology 14 1113824-1113824. .
-
Altes, G; Vaquero, M; Cuesta, S; Anerillas, C; Macia, A; Espinet, C; Ribera, J; Bellusci, S; Klein, OD; Yeramian, A; Dolcet, X; Egea, J; Encinas, M
A dominant negative mutation uncovers cooperative control of caudal Wolffian duct development by Sprouty genes
Cellular And Molecular Life Sciences 79 514-514. .
-
Olabiyi, BF; Fleitas, C; Zammou, B; Ferrer, I; Rampon, C; Egea, J; Espinet, C
proNGF Involvement in the Adult Neurogenesis Dysfunction in Alzheimer's Disease
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 22 -. .
-
Fleitas C; Marfull-Oromí P; Chauhan D; Del Toro D; Peguera B; Zammou B; Rocandio D; Klein R; Espinet C; Egea J
FLRT2 and FLRT3 cooperate in maintaining the tangential migratory streams of cortical interneurons during development.
JOURNAL OF NEUROSCIENCE 41 7350-7362. .
-
Marfull-Oromí P; Fleitas C; Zammou B; Rocandio D; Ballester-Lurbe B; Terrado J; Perez-Roger I; Espinet C; Egea J
Genetic ablation of the Rho GTPase Rnd3 triggers developmental defects in internal capsule and the globus pallidus formation.
JOURNAL OF NEUROCHEMISTRY 158 197-216. .
-
Fleitas, C; Piñol-Ripoll G; Marfull, P; Rocandio, D; Ferrer, I; Rampon, C; Egea, J; Espinet, C
proBDNF is modified by advanced glycation end products in Alzheimer's disease and causes neuronal apoptosis by inducing p75 neurotrophin receptor processing
MOLECULAR BRAIN 11 68-68. .
-
Espinet, C.; Pinol, G.; Fleitas, C.; Arias, A.; Blasco, E.
Imbalance in BDNF and probdnf levels in serum and cerebroespinal fluid in untreated Alzheimer's disease patients
JOURNAL OF NEUROCHEMISTRY 142 156-156. .
-
Espinet C; Gonzalo H; Fleitas C; Menal MJ; Egea J
Oxidative Stress and Neurodegenerative Diseases: A Neurotrophic Approach
CURRENT DRUG TARGETS 16 20-30. .
-
Real, Sebastian; Espada, Lilia; Espinet, Carme; Santidrian, Antonio F.; Tauler, Albert
Study of the in vivo phosphorylation of E2F1 on Ser403
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH 1803 912-918. .
-
Kichev, Anton; Ilieva, Ekaterina V.; Pinol-Ripoll, Gerard; Podlesniy, Petar; Ferrer, Isidro; Portero-Otin, Manuel; Pamplona, Reinald; Espinet, Carme
Cell death and learning impairment in mice caused by in vitro modified pro-NGF can be related to its increased oxidative modifications in Alzheimer disease.
AMERICAN JOURNAL OF PATHOLOGY 175 2574-2585. .
-
Espada, Lilia; Udapudi, Basavaraj; Podlesniy, Petar; Fabregat, Isabel; Espinet, Carme; Tauler, Albert
Apoptotic action of E2F1 requires glycogen synthase kinase 3-beta activity in PC12 cells
JOURNAL OF NEUROCHEMISTRY 102 2020-2028. .
-
Podlesniy, P; Kichev, A; Pedraza, C; Saurat, J; Encinas, M; Perez, B; Ferrer, I; Espinet, C
Pro-NGF from Alzheimer's disease and normal human brain displays distinctive abilities to induce processing and nuclear translocation of intracellular domain of p75NTR and apoptosis.
AMERICAN JOURNAL OF PATHOLOGY 169 119-131. .
Projectes
- Identificació de nous compostos bioactius de naturalesa peptídica en plantes mediterrànies i estudi del seu potencial teràpeutic, optimitzada biodisponibilitat i mecanisme funcional
- ProNGF/p75NTR signalling in hippocampal adult neurogenesis: potential target for generating new neurons in Alzeimer's disease
- Análisis de las proteínas multifuncionales FLRTs en la migración de interneuronas y los mecanismos de señalización implicados
- Interacción entre estrés oxidativo y de retículo en la patogénesis de la esclerosis lateral amiotrófica